Lessee, Operating Lease, Liability, to be Paid in USD of Seres Therapeutics, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Seres Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q1 2019 to Q3 2025.
  • Seres Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2025 was $123M, a 13.6% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Seres Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $123M -$19.4M -13.6% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $128M -$40.3M -23.9% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $133M -$40.8M -23.5% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $138M -$39.5M -22.3% Dec 31, 2024 10-K 2025-03-13
Q3 2024 $143M -$35.9M -20.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $168M -$14.5M -7.94% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $174M -$10M -5.44% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $177M -$9.82M -5.25% Dec 31, 2023 8-K 2024-08-15
Q3 2023 $179M +$145M +430% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $183M +$147M +412% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $184M +$147M +397% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $187M +$155M +490% Dec 31, 2022 10-K 2023-03-07
Q3 2022 $33.7M Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $35.7M Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $36.9M Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $31.7M +$13.7M +76.3% Dec 31, 2021 10-K 2022-03-01
Q4 2020 $18M -$6.3M -25.9% Dec 31, 2020 10-K 2021-03-02
Q4 2019 $24.3M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $25.9M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $27.7M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $29.3M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.